Anthocyanin supplementation in adults at risk for dementia: a randomized controlled trial on its cardiometabolic and anti-inflammatory biomarker effects.
Saved in:
| Title: | Anthocyanin supplementation in adults at risk for dementia: a randomized controlled trial on its cardiometabolic and anti-inflammatory biomarker effects. |
|---|---|
| Authors: | Borda MG; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Helse Stavanger HF, Postboks 8100, 4068, Stavanger, Norway. mmborda@gmail.com.; Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain. mmborda@gmail.com.; Centro de Investigación en Ciencias de La Salud (CICSA), FCS, Universidad Anáhuac México, Huixquilucan Edo. de México, México. mmborda@gmail.com., Ramírez-Vélez R; Navarrabiomed, IdiSNA, Hospital Universitario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Pamplona, Spain., Botero-Rodriguez F; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Helse Stavanger HF, Postboks 8100, 4068, Stavanger, Norway.; SynaptIA - Inteligencia artificial para la investigación en salud mental, Bogotá, Colombia.; Centro de Memoria y Cognición Intellectus, Hospital Universitario San Ignacio, Bogotá, Colombia., Patricio-Baldera J; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Helse Stavanger HF, Postboks 8100, 4068, Stavanger, Norway.; Instituto de Investigación en Salud, Facultad de Ciencias de La Salud de La Universidad Autónoma de Santo Domingo, Santo Domingo, Dominican Republic., de Lucia C; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Helse Stavanger HF, Postboks 8100, 4068, Stavanger, Norway.; Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK., Pola I; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden., Barreto GE; Department of Biological Sciences, University of Limerick, Limerick, Ireland., Khalifa K; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Helse Stavanger HF, Postboks 8100, 4068, Stavanger, Norway., Bergland AK; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Helse Stavanger HF, Postboks 8100, 4068, Stavanger, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Kivipelto M; Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden., Cederholm T; Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, 62167, Uppsala, Sweden.; Theme Inflammation & Ageing, Karolinska University Hospital, Stockholm, Sweden., Zetterberg H; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK, Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin, University of Wisconsin-Madison, Madison, WI, USA., Ashton NJ; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Helse Stavanger HF, Postboks 8100, 4068, Stavanger, Norway.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.; Banner Alzheimer's Institute, University of Arizona, Phoenix, AZ, USA., Ballard C; Medical School, University of Exeter, University of Exeter, Exeter, UK., Siow R; Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.; School of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Sciences & Medicine, British Heart Foundation Centre of Research Excellence, King's College London, London, UK., Aarsland D; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Helse Stavanger HF, Postboks 8100, 4068, Stavanger, Norway.; Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK. |
| Corporate Authors: | NJ FINGER |
| Source: | GeroScience [Geroscience] 2026 Feb; Vol. 48 (1), pp. 563-576. Date of Electronic Publication: 2025 May 02. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-2723 (Electronic) Linking ISSN: 25092723 NLM ISO Abbreviation: Geroscience Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
